Safe use of gemfibrozil in uremic patients on continuous ambulatory peritoneal dialysis

Nephron. 1998;78(3):338. doi: 10.1159/000044948.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Female
  • Gemfibrozil / adverse effects
  • Gemfibrozil / therapeutic use*
  • Humans
  • Hyperlipidemias / chemically induced
  • Hyperlipidemias / drug therapy*
  • Hyperlipidemias / etiology
  • Hypolipidemic Agents / adverse effects
  • Hypolipidemic Agents / therapeutic use*
  • Male
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Uremia / complications
  • Uremia / therapy*

Substances

  • Hypolipidemic Agents
  • Gemfibrozil